EV/EBITDA
-0.07
0.000.00%
3 min ago
Summary
- As of February 12, 2025, SYRS EV/EBITDA is -0.07, unchanged from the previous trading day.
- Over the past year, SYRS EV/EBITDA has increased by +0.64 (+90.14%).
- SYRS EV/EBITDA is now -112.50% below its all-time high of 0.56.
Performance
SYRS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SYRS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | 0.0% | -1.6% | -2.3% |
| 1 m1 month | +22.2% | -18.2% | -24.1% |
| 3 m3 months | +46.1% | -44.8% | -53.7% |
| 6 m6 months | +63.2% | -72.3% | -89.1% |
| ytdytd | +22.2% | -20.4% | -26.8% |
| 1 y1 year | +90.1% | -94.2% | -97.6% |
| 5 y5 years | +98.4% | -97.9% | -99.8% |
SYRS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | -0.09 | +22.2% | |
| 3 m | 3-month | -0.07 | at high | -1.02 | +93.1% |
| 6 m | 6-month | -0.07 | at high | -1.02 | +93.1% |
| 1 y | 1-year | -0.07 | at high | -1.29 | +94.6% |
| 3 y | 3-year | 0.56 | -112.5% | -1.50 | +95.3% |
| 5 y | 5-year | 0.56 | -112.5% | -11.54 | +99.4% |
| alltime | all time | 0.56 | -112.5% | -11.54 | +99.4% |
Syros Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.07(-22.2%) |
| 2024 | -0.09(-89.3%) |
| 2023 | -0.84(-333.3%) |
| 2022 | 0.36(-116.4%) |
| 2021 | -2.20(-65.3%) |
| Date | Value |
|---|---|
| 2020 | -6.34(+62.1%) |
| 2019 | -3.91(+71.5%) |
| 2018 | -2.28(-46.1%) |
| 2017 | -4.23(-12.6%) |
| 2016 | -4.84 |
FAQ
- What is Syros Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Syros Pharmaceuticals?
- What is SYRS EV/EBITDA year-to-date change?
- What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
What is Syros Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SYRS is -0.07
What is the all time high EV/EBITDA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high EV/EBITDA is 0.56
What is SYRS EV/EBITDA year-to-date change?
Syros Pharmaceuticals EV/EBITDA has changed by +0.02 (+22.22%) since the beginning of the year
What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SYRS EV/EBITDA has changed by +0.64 (+90.14%)